Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors
Clinical trial NCT05660421 · WITHDRAWN
Trial details
- NCT number
- NCT05660421
- Sponsor
- Douglas Johnson
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-03
- Primary completion
- 2025-04-03
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.